Erythropoietin treatment and the risk of hip fractures in hemodialysis patients

医学 促红细胞生成素 贫血 血液透析 红细胞生成 危险系数 内科学 比例危险模型 髋部骨折 骨重建 肾脏疾病 骨病 骨髓 泌尿科 外科 骨质疏松症 置信区间
作者
Sukanya Suresh,Elizabeth C. Wright,Daniel G. Wright,Kevin C. Abbott,Constance Tom Noguchi
出处
期刊:Journal of Bone and Mineral Research [Wiley]
卷期号:36 (7): 1211-1219 被引量:9
标识
DOI:10.1002/jbmr.4297
摘要

ABSTRACT Erythropoietin (EPO) is the primary regulator of bone marrow erythropoiesis. Mouse models have provided evidence that EPO also promotes bone remodeling and that EPO-stimulated erythropoiesis is accompanied by bone loss independent of increased red blood cell production. EPO has been used clinically for three decades to treat anemia in end-stage renal disease, and notably, although the incidence of hip fractures decreased in the United States generally after 1990, it rose among hemodialysis patients coincident with the introduction and subsequent dose escalation of EPO treatment. Given this clinical paradox and findings from studies in mice that elevated EPO affects bone health, we examined EPO treatment as a risk factor for fractures in hemodialysis patients. Relationships between EPO treatment and hip fractures were analyzed using United States Renal Data System (USRDS) datasets from 1997 to 2013 and Consolidated Renal Operations in a Web-enabled Network (CROWNWeb) datasets for 2013. Fracture risks for patients treated with <50 units of EPO/kg/week were compared to those receiving higher doses by multivariable Cox regression. Hip fracture rates for 747,832 patients in USRDS datasets (1997–2013) increased from 12.0 per 1000 patient years in 1997 to 18.9 in 2004, then decreased to 13.1 by 2013. Concomitantly, average EPO doses increased from 11,900 units/week in 1997 to 18,300 in 2004, then decreased to 8,800 by 2013. During this time, adjusted hazard ratios for hip fractures with EPO doses of 50–149, 150–299, and ≥ 300 units/kg/week compared to <50 units/kg/week were 1.08 (95% confidence interval [CI], 1.01–1.15), 1.22 (95% CI, 1.14–1.31), and 1.41 (95% CI, 1.31–1.52), respectively. Multivariable analyses of 128,941 patients in CROWNWeb datasets (2013) replicated these findings. This study implicates EPO treatment as an independent risk factor for hip fractures in hemodialysis patients and supports the conclusion that EPO treatment may have contributed to changing trends in fracture incidence for these patients during recent decades. Published 2021. This article is a U.S. Government work and is in the public domain in the USA. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
野性的小懒虫完成签到 ,获得积分10
1秒前
汉堡包应助淡然白安采纳,获得10
1秒前
赘婿应助sybil采纳,获得10
2秒前
ariaooo发布了新的文献求助10
2秒前
2秒前
荣誉完成签到,获得积分10
3秒前
来日可期发布了新的文献求助10
3秒前
浅步调完成签到 ,获得积分10
5秒前
5秒前
5秒前
王灿灿发布了新的文献求助10
5秒前
传奇3应助whh采纳,获得50
5秒前
子暮完成签到,获得积分10
6秒前
小勇仔完成签到,获得积分10
6秒前
ariaooo完成签到,获得积分10
7秒前
8秒前
ximomm完成签到,获得积分10
8秒前
小问号完成签到,获得积分10
8秒前
9秒前
9秒前
wanci发布了新的文献求助10
9秒前
曲书文发布了新的文献求助10
9秒前
9秒前
Calvin-funsom完成签到,获得积分10
10秒前
会撒娇的金鑫完成签到,获得积分20
10秒前
爱静静应助cosmos007采纳,获得10
10秒前
粒粒发布了新的文献求助10
10秒前
浪里白条完成签到,获得积分10
10秒前
李爱国应助小勇仔采纳,获得10
11秒前
11秒前
11秒前
12秒前
sq753421发布了新的文献求助30
12秒前
fissh发布了新的文献求助10
12秒前
研友_VZG7GZ应助勤能补拙采纳,获得10
12秒前
13秒前
苯二氮卓完成签到 ,获得积分10
13秒前
13秒前
追月亮的星星完成签到,获得积分10
13秒前
高分求助中
Evolution 3rd edition 1500
Lire en communiste 1000
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 700
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 700
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
2-Acetyl-1-pyrroline: an important aroma component of cooked rice 500
Ribozymes and aptamers in the RNA world, and in synthetic biology 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3180500
求助须知:如何正确求助?哪些是违规求助? 2830796
关于积分的说明 7981033
捐赠科研通 2492477
什么是DOI,文献DOI怎么找? 1329555
科研通“疑难数据库(出版商)”最低求助积分说明 635745
版权声明 602954